Skip to main content

Animations

MJFF Publications

5331 - 5340 of 9117 Results
Title
Year
  • Year
  • 2022
  • 2018
  • 2023
  • 2014
  • 2025
  • 2019
  • 2019
  • 2025
  • 2018
  • 2020
  • Summary Details
    OPEN
    Title: Foundations of circadian medicine
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3001567
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Pink1 −/− Rats Show Early-Onset Swallowing Deficits and Correlative Brainstem Pathology
    Journal Name: Dysphagia
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00455-018-9896-5
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
    Journal Name: Brain, Behavior, & Immunity - Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.bbih.2023.100656
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Concomitant pathologies among a spectrum of parkinsonian disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012
    Citation Count: 164
  • Summary Details
    OPEN
    Title: Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment
    Journal Name: Cellular Signalling
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cellsig.2025.111716
    Citation Count: 5
  • Hypertension and progressive supranuclear palsy
    2019
    Summary Details
    RESTRICTED
    Title: Hypertension and progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.036
    Citation Count: 24
  • Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells
    2019
    Summary Details
    RESTRICTED
    Title: Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells
    Journal Name: Nanoscale
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1039/c9nr01277j
    Citation Count: 79
  • Assessment of SLC25A46 variants in idiopathic Parkinson's disease
    2025
    Summary Details
    RESTRICTED
    Title: Assessment of SLC25A46 variants in idiopathic Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108092
    Citation Count: 1
  • Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    2018
    Summary Details
    RESTRICTED
    Title: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27392
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.25944
    Citation Count: 75
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.